US Stock MarketDetailed Quotes

MDGL Madrigal Pharmaceuticals

Watchlist
  • 326.040
  • -5.410-1.63%
Trading Nov 29 12:35 ET
7.11BMarket Cap-13025P/E (TTM)

Madrigal Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
62.18M
14.64M
0
0
0
0
0
0
0
0
Operating revenue
--62.18M
--14.64M
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
2.15M
636K
0
0
Gross profit
60.02M
14M
0
0
Operating expense
78.95%176.33M
104.21%176.54M
94.08%152.04M
29.61%380.5M
37.37%117.18M
22.54%98.53M
23.02%86.45M
36.03%78.34M
21.07%293.57M
32.04%85.3M
Selling and administrative expenses
290.04%107.59M
490.91%105.45M
399.32%80.8M
124.70%108.15M
219.68%46.54M
127.19%27.58M
51.56%17.85M
67.55%16.18M
28.97%48.13M
24.29%14.56M
-General and administrative expense
290.04%107.59M
----
----
124.70%108.15M
219.68%46.54M
127.19%27.58M
----
----
28.97%48.13M
24.29%14.56M
Research and development costs
-3.11%68.74M
3.62%71.09M
14.61%71.24M
10.96%272.35M
-0.14%70.64M
3.93%70.95M
17.28%68.61M
29.68%62.15M
19.63%245.44M
33.76%70.74M
Operating profit
-18.03%-116.3M
-88.01%-162.54M
-94.08%-152.04M
-29.61%-380.5M
-37.37%-117.18M
-22.54%-98.53M
-23.02%-86.45M
-36.03%-78.34M
-21.07%-293.57M
-32.04%-85.3M
Net non-operating interest income expense
4,633.98%9.34M
1,525.54%10.57M
212.22%4.5M
485.95%6.87M
922.11%4.98M
73.76%-206K
242.23%650K
1,986.96%1.44M
-590.08%-1.78M
-1,265.38%-606K
Non-operating interest income
294.75%13.02M
300.51%14.22M
120.71%8.33M
796.02%19.58M
732.06%8.95M
359.97%3.3M
999.38%3.55M
5,372.46%3.78M
501.93%2.19M
1,969.23%1.08M
Non-operating interest expense
4.99%3.68M
26.03%3.66M
64.30%3.84M
220.69%12.71M
136.09%3.97M
133.29%3.5M
271.92%2.9M
--2.34M
--3.96M
--1.68M
Other net income (expense)
Income before tax
-8.33%-106.96M
-77.12%-151.97M
-91.87%-147.54M
-26.50%-373.63M
-30.60%-112.19M
-21.61%-98.74M
-21.31%-85.8M
-33.69%-76.9M
-22.12%-295.35M
-33.08%-85.91M
Income tax
Net income
-8.33%-106.96M
-77.12%-151.97M
-91.87%-147.54M
-26.50%-373.63M
-30.60%-112.19M
-21.61%-98.74M
-21.31%-85.8M
-33.69%-76.9M
-22.12%-295.35M
-33.08%-85.91M
Net income continuous Operations
-8.33%-106.96M
-77.12%-151.97M
-91.87%-147.54M
-26.50%-373.63M
-30.60%-112.19M
-21.61%-98.74M
-21.31%-85.8M
-33.69%-76.9M
-22.12%-295.35M
-33.08%-85.91M
Minority interest income
Net income attributable to the parent company
-8.33%-106.96M
-77.12%-151.97M
-91.87%-147.54M
-26.50%-373.63M
-30.60%-112.19M
-21.61%-98.74M
-21.31%-85.8M
-33.69%-76.9M
-22.12%-295.35M
-33.08%-85.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-8.33%-106.96M
-77.12%-151.97M
-91.87%-147.54M
-26.50%-373.63M
-30.60%-112.19M
-21.61%-98.74M
-21.31%-85.8M
-33.69%-76.9M
-22.12%-295.35M
-33.08%-85.91M
Basic earnings per share
7.87%-4.92
-51.39%-7.1
-74.47%-7.38
-16.02%-19.99
-14.86%-5.72
-12.42%-5.34
-13.29%-4.69
-25.89%-4.23
-17.77%-17.23
-31.75%-4.98
Diluted earnings per share
7.87%-4.92
-51.39%-7.1
-74.47%-7.38
-16.02%-19.99
-14.86%-5.72
-12.42%-5.34
-13.29%-4.69
-25.89%-4.23
-17.77%-17.23
-31.75%-4.98
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 62.18M14.64M00000000
Operating revenue --62.18M--14.64M--0--0--0--0--0--0--0--0
Cost of revenue 2.15M636K00
Gross profit 60.02M14M00
Operating expense 78.95%176.33M104.21%176.54M94.08%152.04M29.61%380.5M37.37%117.18M22.54%98.53M23.02%86.45M36.03%78.34M21.07%293.57M32.04%85.3M
Selling and administrative expenses 290.04%107.59M490.91%105.45M399.32%80.8M124.70%108.15M219.68%46.54M127.19%27.58M51.56%17.85M67.55%16.18M28.97%48.13M24.29%14.56M
-General and administrative expense 290.04%107.59M--------124.70%108.15M219.68%46.54M127.19%27.58M--------28.97%48.13M24.29%14.56M
Research and development costs -3.11%68.74M3.62%71.09M14.61%71.24M10.96%272.35M-0.14%70.64M3.93%70.95M17.28%68.61M29.68%62.15M19.63%245.44M33.76%70.74M
Operating profit -18.03%-116.3M-88.01%-162.54M-94.08%-152.04M-29.61%-380.5M-37.37%-117.18M-22.54%-98.53M-23.02%-86.45M-36.03%-78.34M-21.07%-293.57M-32.04%-85.3M
Net non-operating interest income expense 4,633.98%9.34M1,525.54%10.57M212.22%4.5M485.95%6.87M922.11%4.98M73.76%-206K242.23%650K1,986.96%1.44M-590.08%-1.78M-1,265.38%-606K
Non-operating interest income 294.75%13.02M300.51%14.22M120.71%8.33M796.02%19.58M732.06%8.95M359.97%3.3M999.38%3.55M5,372.46%3.78M501.93%2.19M1,969.23%1.08M
Non-operating interest expense 4.99%3.68M26.03%3.66M64.30%3.84M220.69%12.71M136.09%3.97M133.29%3.5M271.92%2.9M--2.34M--3.96M--1.68M
Other net income (expense)
Income before tax -8.33%-106.96M-77.12%-151.97M-91.87%-147.54M-26.50%-373.63M-30.60%-112.19M-21.61%-98.74M-21.31%-85.8M-33.69%-76.9M-22.12%-295.35M-33.08%-85.91M
Income tax
Net income -8.33%-106.96M-77.12%-151.97M-91.87%-147.54M-26.50%-373.63M-30.60%-112.19M-21.61%-98.74M-21.31%-85.8M-33.69%-76.9M-22.12%-295.35M-33.08%-85.91M
Net income continuous Operations -8.33%-106.96M-77.12%-151.97M-91.87%-147.54M-26.50%-373.63M-30.60%-112.19M-21.61%-98.74M-21.31%-85.8M-33.69%-76.9M-22.12%-295.35M-33.08%-85.91M
Minority interest income
Net income attributable to the parent company -8.33%-106.96M-77.12%-151.97M-91.87%-147.54M-26.50%-373.63M-30.60%-112.19M-21.61%-98.74M-21.31%-85.8M-33.69%-76.9M-22.12%-295.35M-33.08%-85.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -8.33%-106.96M-77.12%-151.97M-91.87%-147.54M-26.50%-373.63M-30.60%-112.19M-21.61%-98.74M-21.31%-85.8M-33.69%-76.9M-22.12%-295.35M-33.08%-85.91M
Basic earnings per share 7.87%-4.92-51.39%-7.1-74.47%-7.38-16.02%-19.99-14.86%-5.72-12.42%-5.34-13.29%-4.69-25.89%-4.23-17.77%-17.23-31.75%-4.98
Diluted earnings per share 7.87%-4.92-51.39%-7.1-74.47%-7.38-16.02%-19.99-14.86%-5.72-12.42%-5.34-13.29%-4.69-25.89%-4.23-17.77%-17.23-31.75%-4.98
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data